Amazing! Genetic therapy , personalized to each individual, for free, for life! Inspiring - treating the untreatable
#RareDisease

We are making progress on understanding the mechanisms by which APOL1 risk variants mediate #CKD #ESKD and #FSGS but still many questions are open … read this perspective .. more to come ! At the end, as usual, nothing is simple and different mechanisms, different cell types ,

JASN Editorial Board lunch reunion at WCN in Buenos Aires!!! Good to see the team in person rather than in zoom, especially with great food in front! Too bad many were not here.... next at ASN? #ISNWCN
JASN_News American Society of Nephrology Rajnish Mehrotra Lilia Cervantes Petter Bjornstad, M.D.

Neglecting rare disease poses important concerns about equitable care, especially for vulnerable populations!
Thank you to all attendees who came to this session despite being the last of the congress and at the same time of other excellent sessions!
#FSGS #CAKUT

From airport to restaurant ! Hello Buenos Aires!!
#ISNWCN
American Society of Nephrology Int Society of Nephrology American Society of Pediatric Nephrology IPNA Ped Nephrology

Can’t miss this session!! Genetic kidney diseases rule!
#CAKUT #FSGS #rarediseases #alport #ADPKD #ADTKD #COL4A #rarekidneydisease

Packing for #ISNWCN to go check on great science , meet friends and collaborators, and give a talk on #FSGS
Int Society of Nephrology International Society of Glomerular Disease Columbia Glomerular Center GlomCon American Society of Pediatric Nephrology American Society of Nephrology NephCure Nephrotic Syndrome Foundation Pediatric Nephrology Research Consortium IPNA Ped Nephrology Rajnish Mehrotra

And here we go after the talk at the food and science reception !!
ASCI
goutham narla
Carlos D. Bustamante 🇻🇪🇺🇸

Great talk at ASCI by Carlos D. Bustamante 🇻🇪🇺🇸 !
Crawl->walk->run->fly!! Towards 10M genomes on truly diverse populations! Representation of genetic diversity means equitable genetic discoveries that translate in equitable precision medicine. Fantastic effort by
Galatea Bio

Welcome to ASCI my dear friend!!!
Congratulations! Well deserved

This still remains one of the most important and sober comment on the All of Us paper, especially the last lines “… a message that can be misinterpreted by the public” —> clearly no AoU investigator nor any geneticist has an agenda to use genetic variation to define rigid

Starting this year #ASCI meeting with energy

ASCI

Frontiers in gene therapy! Nothing is untreatable. The only thing that makes a disease untreatable is the neglect from funding agencies. Rare diseases have all the potential to be treatable, if the right investment is made, and they serve as proof of concept and platform for drug

Thank you all Shipra Agrawal Sian Piret 🏴󠁧󠁢󠁷󠁬󠁳󠁿 Sandeep K. Mallipattu et al for the kind invitation and warm reception to Stony Brook Nephrology & Hypertension Division Stony Brook Department of Medicine . It’s been a true pleasure to meet faculty and fellows . It’s such a young, collaborative and dynamic group of people that, I have to say, is rare to

This looks really awesome! Thank you Veera Rajagopal  for the quick but precise summary ! This article is pinned for internal presentation at lab meeting, cant wait to delve in it!
#CNV

Fantastic!!
Great and encouraging news for patients with #APOL1 mediated kidney disease and #FSGS
APOLLO_Network13 Nephrotic Syndrome Foundation GlomCon Columbia Glomerular Center NephCure International Society of Glomerular Disease

Freshly printed and with a beautiful cover :)
Lot of contents
#FSGS #CAKUT #humangenetics #pediatrics #nephrology

More about development!! Thank you @nature! What paper and what a resource !!!
#CAKUT

Great meeting, and with excellent representation of patients with their motivating stories.
Marcus Pezzolesi Gbadegesin Lab